MiNK Therapeutics (6Q40.F) Q4 2024 Earnings

14NovConfirmed
Q4 2024
-0.76
-0.67
-0.57
-0.47

Details

Expected EPS
-0.76036142322
Actual EPS
-0.47483
Surprise EPS
0.29
Surprise Percent
+37.55%

Description

MiNK Therapeutics (6Q40.F) has reported earnings of -0.47483 per share for Q4 2024.

0 Comments

Share your thoughts